The low P/S ratio is likely due to investors' concerns about the company's poor revenue performance and underwhelming growth outlook. The company will need a significant change in fortune to justify a higher P/S ratio in the future.
$フォートレス(FBIO.US)$$ムスタング バイオ(MBIO.US)$City of Hope-developed Chimeric Antigen Receptor (CAR) T Cell Therapy Shows Clinical Activity in Patients With Aggressive Brain Tumors in a Phase 1 Trial 4 MINUTES AGO, 5:00 AM EST VIA BUSINESSWIRE • Half of the enrolled patients had stable disease for at least two months, two showed partial response and two experienced complete response • Nature Medicine paper highlights delivery of CAR T cell therapy directly to the brain, a technique Ci...
Trytosaveabitスレ主Newbiemooer:
Sorry was busy! When I posted MBIO was at 1.32 for about 11 minutes. It jumped to 2.16 and I was out 2.04 for 50%! If it drops below 1.53? I may get back in? Then from there my first scale out depending on chart/volume would be 2.40! Sry like I said was in the middle of a trade when I answered you a few minutes ago! GL
$フォートレス(FBIO.US)$Fortress Biotech And Cyprium Therapeutics Announce $4.1M Grant From NINDS To Further ThenDevelopment Of AAV-ATP7A Gene Therapy For Menkes Disease
Fortress Biotech's low P/S ratio may be due to anticipated poor growth or falling revenue. Its forecast growth being lower than the industry average could be causing its P/S to lag behind peers. This suggests the share price may not rise significantly soon.
フォートレスに関するコメント
4 MINUTES AGO, 5:00 AM EST
VIA BUSINESSWIRE
• Half of the enrolled patients had stable disease for at least two months, two showed partial response and two experienced complete response
• Nature Medicine paper highlights delivery of CAR T cell therapy directly to the brain, a technique Ci...
$オプテイノ-ズ(OPTN.US)$
when are the next date for $チェックポイント セラピューティクス(CKPT.US)$ , $フォートレス(FBIO.US)$ , and $ブレインストーム セル セラピューティクス(BCLI.US)$ ?
all of these stocks currently not good fundamentally... some even minus PBV
Hope miracle happens suddenly shows up an acquisition news like $Gracell Biotechnologies(GRCL.US)$ by ...
まだコメントはありません